Patients with multiple sclerosis who experience disease breakthrough often switch disease-modifying therapy, so researchers compared the efficacy of highly effective DMT with moderately effective DMT,...
How do you discuss the safety risks associated with driving with your patients with dementia or mild cognitive impairment? This new guideline can help you start the conversation.
After studying the results of 3 brief cognitive assessments administered to more than 800 patients, researchers determined whether the tests could accurately classify dementia.
The FDA has released a warning about the potential for an increase in disability in patients with multiple sclerosis who stop taking this immunosuppressant.
Researchers of a study presented at the APHA Annual Meeting & Expo determined whether patients with dementia experience certain symptoms at a higher rate than those without the condition.
Researchers at the APHA’s Annual Meeting & Expo presented their findings on the connection between risk factors for cognitive decline and cardiovascular disease.
As marijuana continues to be legalized in more areas of the United States, it is important to clarify its association with major health outcomes, including stroke. Researchers investigated this further in a...
